More than 85% of cancer patients developed COVID-19 antibodies after a second dose of Pfizer
[ad_1] Cancer patients are likely to develop protection against COVID-19 when they receive two doses of a vaccine, a new study suggests. Researchers found that,… Read More »More than 85% of cancer patients developed COVID-19 antibodies after a second dose of Pfizer